Potential role of glucagon-like peptide-1 receptor agonists in the treatment of cognitive decline and dementia in diabetes mellitus
These impacts range from their relationships with food to how they feel about their personal appearance to what they want to buy and how they want to dine, said Kathy Risch, SVP of Thought Leadership and Shopper Insights for Acosta Group
Patients with T2D not adequately controlled on therapy with metformin and insulin glargine as baseline therapy received either tirzepatide at the doses used in the SURPASS trials or placebo during the 40-week study setting
Available strengths include 10mg, 12mg, 15mg, 20mg, 24mg, 30mg, and 40mg, providing flexibility for both small-scale and long-term research projects
But the ads Ive seen overwhelmingly focus on cosmetic changes, not improved health
Foods to Avoid Certain foods can exacerbate GLP-1 side effects